Xequecal wrote:
I'm not following your cause and effect here. First, how does the "fact" (I can find no info on this supposed mass killing whatsoever) that an FDA clinical trial failed to produce a viable drug treatment somehow make the government responsible for the situation where one must fork out six figures for a drug in order to continue living?
Actually, the Epogen situation explains why there aren't generic biologics. You don't seem to get that.
Xequecal wrote:
Second, Epogen is not what I'm talking about. The cancer "wonder drug" I'm referring to is Gleevec/Imatinib, which costs over ten times as much as Epogen does at $92,000/year. For a while it was the only effective treatment for CML, today there are several other drugs but all of them are also under patent and all are even more expensive.
It doesn't cost $92,000 a year. You don't have time to take 46000 pills in 365 days.
Xequecal wrote:
Third, it's interesting you bring up Epogen, as it's a pretty fine example of what's so wrong with capitalist health care. By stringing out their patent registrations, Amgen has managed to give themselves a >30 year monopoly on the sale of any and all human erythropoietin. This is an especially egregious case, they've managed to secure a monopoly on an amino acid sequence, making billions by price gouging dying patients that are not legally allowed to receive treatment from anyone else. At least Gleevec has actual competition, Amgen gets to decide by itself who lives and who dies.
The FDA Contributed funding to a German company attempting to develop a generic equivalent to Epogen. The 400 trial subjects died. You don't understand enough about medications and biologic medications to understand why those patents are being protecting. Their production and development is not just basic chemistry. More to the point, it's all human safe lab produced erythropoietin. The monopoly here exists solely because no one can produce a function generic.
Xequecal wrote:
Fourth, the "median age" is totally irrelevant, you said it was impossible for someone to bankrupt themselves, and that includes everyone on the tail end of the bell curve.
It was. The healthcare plan your defending changed that. But, you know, keep trying to us we're wrong and don't know how things work. It's 2013. The ACA was signed into law in 2010. You now have 3 years of propaganda created by immediate implementation components convincing you to support the bill. The ACA changed the ability-to-pay calculations and standards. The ACA changed Medicare Part D and Medicaid subscription subsidies. The ACA allowed providers to demand payment based on new ability-to-pay calculations and has lead to a situation wherein people are NOW going bankrupt. These were ALL intentional parts of the bill and parts of first-wave implementation.
Incidentally, I also mention Epogen because it's no long covered by Medicaid/Medicare. Amgen, in fact, is likely to go out of business because of that (which doesn't really bother me, except they're in the business of developing curative biologics and keep getting cockblocked by Sibelius). Competition doesn't work for biologics. Epogen is manufactured using a specific porcine fetal protein substrate. The only part of the process you can alter, because you're manufacturing a biologic, is the starting protein medium. Gleevec, on the other hand, is a chemical medicine and doesn't cost 92,000 a year except using projected calculations based on paying maximum MSRP per dose.
_________________
Corolinth wrote:
Facism is not a school of thought, it is a racial slur.